The pharmaceutical industry versus Medicaid--limits on state initiatives to control prescription-drug costs.
Mello
Michelle M
MM
Department of Health Policy and Management, Harvard School of Public Health, Boston, USA.
Studdert
David M
DM
Brennan
Troyen A
TA
D016527:Drug Costs / Q000331:legislation & jurisprudence*; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D008484:Medicaid / Q000331:legislation & jurisprudence*; D011306:Prescription Fees / Q000331:legislation & jurisprudence*; D011907:Rate Setting and Review / Q000331:legislation & jurisprudence*; D013221:State Health Plans / Q000331:legislation & jurisprudence*; D014481:United States